Application of Baricitinib in Dermatology

There are four JAK subtypes: JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2). Small molecule Janus tyrosine kinase (JAK) inhibitors can inhibit a variety of pro-inflammatory cytokines. Baricitinib is the first generation of JAK1/2 inhibitor targeting the ATPase of JAK, which blocks the intracellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingya, Qi, Fei, Dong, Jie, Tan, Yaqi, Gao, Ling, Liu, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939862/
https://www.ncbi.nlm.nih.gov/pubmed/35330989
http://dx.doi.org/10.2147/JIR.S356316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939862/
https://www.ncbi.nlm.nih.gov/pubmed/35330989
http://dx.doi.org/10.2147/JIR.S356316

Ejemplares similares